204 related articles for article (PubMed ID: 11259549)
1. A-85380 and epibatidine each interact with disparate spinal nicotinic receptor subtypes to achieve analgesia and nociception.
Khan IM; Stanislaus S; Zhang L; Taylor P; Yaksh TL
J Pharmacol Exp Ther; 2001 Apr; 297(1):230-9. PubMed ID: 11259549
[TBL] [Abstract][Full Text] [Related]
2. Nociceptive and antinociceptive responses to intrathecally administered nicotinic agonists.
Khan IM; Buerkle H; Taylor P; Yaksh TL
Neuropharmacology; 1998 Dec; 37(12):1515-25. PubMed ID: 9886674
[TBL] [Abstract][Full Text] [Related]
3. Epibatidine binding sites and activity in the spinal cord.
Khan IM; Yaksh TL; Taylor P
Brain Res; 1997 Apr; 753(2):269-82. PubMed ID: 9125412
[TBL] [Abstract][Full Text] [Related]
4. Enhanced antinociception by nicotinic receptor agonist epibatidine and adrenal medullary transplants in the spinal subarachnoid space.
Caban AJ; Hama AT; Lee JW; Sagen J
Neuropharmacology; 2004 Jul; 47(1):106-16. PubMed ID: 15165838
[TBL] [Abstract][Full Text] [Related]
5. Differences between the antinociceptive effects of the cholinergic channel activators A-85380 and (+/-)-epibatidine in rats.
Curzon P; Nikkel AL; Bannon AW; Arneric SP; Decker MW
J Pharmacol Exp Ther; 1998 Dec; 287(3):847-53. PubMed ID: 9864263
[TBL] [Abstract][Full Text] [Related]
6. (+/-) Epibatidine increases acetylcholine release partly through an action on muscarinic receptors.
Kommalage M; Höglund AU
Basic Clin Pharmacol Toxicol; 2004 May; 94(5):238-44. PubMed ID: 15125694
[TBL] [Abstract][Full Text] [Related]
7. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
[TBL] [Abstract][Full Text] [Related]
8. Intrathecal nicotinic agonist-elicited release of excitatory amino acids as measured by in vivo spinal microdialysis in rats.
Khan IM; Marsala M; Printz MP; Taylor P; Yaksh TL
J Pharmacol Exp Ther; 1996 Jul; 278(1):97-106. PubMed ID: 8764340
[TBL] [Abstract][Full Text] [Related]
9. Neuropathy-specific analgesic action of intrathecal nicotinic agonists and its spinal GABA-mediated mechanism.
Rashid MH; Ueda H
Brain Res; 2002 Oct; 953(1-2):53-62. PubMed ID: 12384238
[TBL] [Abstract][Full Text] [Related]
10. Evidence for nicotinic receptors potentially modulating nociceptive transmission at the level of the primary sensory neuron: studies with F11 cells.
Puttfarcken PS; Manelli AM; Arneric SP; Donnelly-Roberts DL
J Neurochem; 1997 Sep; 69(3):930-8. PubMed ID: 9282914
[TBL] [Abstract][Full Text] [Related]
11. Presynaptic alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate [3H]d-aspartate release from rat frontal cortex in vitro.
Rousseau SJ; Jones IW; Pullar IA; Wonnacott S
Neuropharmacology; 2005 Jul; 49(1):59-72. PubMed ID: 15992581
[TBL] [Abstract][Full Text] [Related]
12. Agonist-induced up-regulation of alpha4beta2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition.
Whiteaker P; Sharples CG; Wonnacott S
Mol Pharmacol; 1998 May; 53(5):950-62. PubMed ID: 9584223
[TBL] [Abstract][Full Text] [Related]
13. Ablation of primary afferent terminals reduces nicotinic receptor expression and the nociceptive responses to nicotinic agonists in the spinal cord.
Khan IM; Wennerholm M; Singletary E; Polston K; Zhang L; Deerinck T; Yaksh TL; Taylor P
J Neurocytol; 2004 Sep; 33(5):543-56. PubMed ID: 15906161
[TBL] [Abstract][Full Text] [Related]
14. Analgesic and toxic effects of ABT-594 resemble epibatidine and nicotine in rats.
Boyce S; Webb JK; Shepheard SL; Russell MGN; Hill RG; Rupniak NMJ
Pain; 2000 Apr; 85(3):443-450. PubMed ID: 10781917
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular and behavioral responses to nicotinic agents administered intrathecally.
Khan IM; Taylor P; Yaksh TL
J Pharmacol Exp Ther; 1994 Jul; 270(1):150-8. PubMed ID: 8035311
[TBL] [Abstract][Full Text] [Related]
16. Analgesic profile of the nicotinic acetylcholine receptor agonists, (+)-epibatidine and ABT-594 in models of persistent inflammatory and neuropathic pain.
Kesingland AC; Gentry CT; Panesar MS; Bowes MA; Vernier JM; Cube R; Walker K; Urban L
Pain; 2000 May; 86(1-2):113-8. PubMed ID: 10779668
[TBL] [Abstract][Full Text] [Related]
17. Modulatory role of estradiol in nicotinic antinociception in adult female rats.
Chen Y; Cui Y; Lin JW; Xiang QL; Liu WF; Wang TH
Life Sci; 2009 Jul; 85(1-2):91-6. PubMed ID: 19427872
[TBL] [Abstract][Full Text] [Related]
18. Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice.
Damaj MI; Fei-Yin M; Dukat M; Glassco W; Glennon RA; Martin BR
J Pharmacol Exp Ther; 1998 Mar; 284(3):1058-65. PubMed ID: 9495867
[TBL] [Abstract][Full Text] [Related]
19. Peripheral nerve injury alters spinal nicotinic acetylcholine receptor pharmacology.
Young T; Wittenauer S; Parker R; Vincler M
Eur J Pharmacol; 2008 Aug; 590(1-3):163-9. PubMed ID: 18573248
[TBL] [Abstract][Full Text] [Related]
20. Nicotinic cholinergic receptors: potential targets for inflammatory pain relief.
Lawand NB; Lu Y; Westlund KN
Pain; 1999 Mar; 80(1-2):291-9. PubMed ID: 10204742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
